Success Metrics

Completion Rate
0%(0/1)
Active Trials
1(33%)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_3
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
2(66.7%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Terminated(1)
Other(1)

Detailed Status

unknown1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (66.7%)
N/A1 (33.3%)

Trials by Status

unknown133%
recruiting133%
terminated133%

Recent Activity

1 active trials
Showing 3 of 3
recruitingnot_applicable

Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial

NCT05899582
unknownphase_3

The Adult Hemorrhagic Moyamoya Surgery Study

NCT02319980
terminatedphase_3

Carotid Occlusion Surgery Study

NCT00029146

Clinical Trials (3)

Showing 3 of 3 trials
NCT05899582Not Applicable

Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial

Recruiting
NCT02319980Phase 3

The Adult Hemorrhagic Moyamoya Surgery Study

Unknown
NCT00029146Phase 3

Carotid Occlusion Surgery Study

Terminated

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3